Background: Part of the heterogeneity of the obesity phenotype may originate from genetic differences between obese individuals that may influence energy expenditure (EE). Objective: To examine if common single-nucleotide polymorphisms (SNPs) in genes related to obesity-associated phenotypes are associated with postabsorptive resting energy expenditure (REE) and postprandial REE in obese individuals. Design and methods: Postabsorptive REE and 3-h postprandial REE (liquid test meal containing 95% fat, energy content 50% of estimated REE) were measured in 743 obese individuals from eight clinical centres in seven European countries. The analysis assessed the association of genotypes of 44 SNPs in 28 obesity-related candidate genes with postabsorptive REE and postprandial REE taking into consideration the influence of body composition, habitual physical activity, insulin sensitivity, circulating thermogenic hormones and metabolites. Results: After adjustment for fat-free mass (FFM), age, sex and research centre, SNPs in CART, GAD2, PCSK1, PPARG3, HSD11B1 and LIPC were significantly associated with postabsorptive REE. SNPs in GAD2, HSD11B1 and LIPC remained significantly associated with postabsorptive REE after further adjustment for fat mass (FM). SNPs in CART, PPARG2 and IGF2 were significantly associated with postprandial REE after similar adjustments. These associations with postprandial REE remained significant after further adjustment for FM. FTO, UCP2 and UCP3 variants were not associated with postabsorptive or postprandial REE. Conclusions: Several gene polymorphisms associated with obesity-related phenotypes but not FTO and UCP variants may be responsible for some of the inter-individual variability in postabsorptive REE and fat-induced thermogenesis unaccounted for by FFM, FM, age and sex. The association between FTO and obesity that has been reported earlier may not be mediated directly through modulation of EE in obese individuals.
Introduction
Weight changes depend on changes in energy balance. The major component accounting for 60-70% of daily energy expenditure (EE) is resting energy expenditure (REE). It is well established that fat-free mass (FFM) is the strongest determinant of REE, accounting for about 80% of interindividual variance in REE. 1 In addition, fat mass (FM), age, sex, habitual physical activity, insulin sensitivity, thermogenic hormones and circulating metabolites contribute to the variance in EE, although their contribution is much less than FFM. [1] [2] [3] Part of the variance in REE remains unexplained, and there is evidence that EE may also be partly genetically determined. 1 For example, it has been shown that the intra-class correlation coefficient for REE in monozygotic twins was much higher than that in dizygotic twins. 4 A large number of genes have been implicated in obesityrelated phenotypes. 5 Perhaps the best documented obesity gene polymorphism is in the FTO gene. 6 An altered efficiency of cellular energy metabolism (reduced adaptive thermogenesis) 7 and/or thermogenic response to food intake 3 may be important factors that could contribute to the heterogeneity of the obesity phenotype. Until now, however, no large-scale studies have been performed that have addressed the importance of genetic background in inter-individual variance in EE in obese individuals who have been phenotyped in detail, especially regarding EE components. The objective of this study was to investigate, using the multi-centre NUGENOB (Nutrient-Gene Interactions in Human Obesity: Implications for Dietary Guidelines) trial (see www.nugenob.org), if common single-nucleotide polymorphisms (SNPs) in a panel of obesity-related candidate genes are associated with EE before and after a high-fat load in 743 obese individuals (553 women). These SNPs were selected on the basis of their known or presumed involvement in various parts of the pathophysiological processes associated with obesity and its related phenotypes. Due to the size of this study in combination with detailed phenotyping, it was possible to control for several factors known to influence EE levels.
Materials and methods

Individuals
A total of 743 obese individuals (553 women) from eight clinical centres in seven European countries (Maastricht, The Netherlands; Nottingham, UK; Paris and Toulouse, France; Pamplona, Spain; Prague, Czech Republic; Stockholm, Sweden; and Copenhagen, Denmark) were included in this study. Study design including inclusion and exclusion criteria have been described earlier in detail. 8 Physical and biochemical characteristics of the individuals are summarized in Table 1 . Briefly, the basic selection criteria were 20-50 years of age and body mass index greater than or equal to 30 kg/m 2 . Exclusion criteria were weight change more than 3 kg within the 3 months before the study start; drug-treated hypertension, diabetes or hyperlipidaemia; untreated thyroid disease; surgically treated obesity; pregnancy; alcohol or drug abuse; and participation in other simultaneous ongoing trials.
The study protocol was approved by the Ethics Committee at each of the participating centres. The nature and risks of the experimental procedure were explained to the individuals, and all individuals gave written informed consent before participating in the study.
Experimental design and procedures
After a 3-day dietary run-in period, in which individuals kept to their habitual diet, avoid alcohol consumption and excessive physical activity, all individuals underwent a 1-day clinical investigation, as described earlier.
3 Individuals arrived at the research centre at 0800 hours after an overnight fast and then reclined for 3.5 h, during which thermogenesis and substrate utilization were measured by indirect calorimetry before and for 3 h after meal intake. 3 The test meal used was liquid and based on double cream with 40% fat per100 g. In two centres, commercial double cream was adjusted with butter to have an equal fat load. Ninety-five percent of energy content of the test meal consisted of fat, of which 60% was saturated fat, 3% consisted of carbohydrate, and 2% consisted of protein, and the meal had an energy density of 1.57 MJ/100 g. On the basis of the predicted basal metabolic rate (WHO, technical report series 724, Geneva, 1985), the energy content was fixed at 50% of predicted 24-h basal metabolic rate. Individuals were asked to consume the test meal within 10 min.
Details regarding measurement of metabolic rate, blood sampling and biochemical analysis have recently been published. 3 An estimate of physical activity was obtained by means of the Baecke questionnaire, using the sum of work, sport and leisure scores as described earlier.
9,10
Calculations Energy expenditure was calculated according to the equation of Weir. 11 Insulin resistance was assessed using the homoeostasis model assessment (HOMA IR ) and calculated from fasting plasma glucose and insulin concentrations according to the equation of Matthews et al. 12 The area under the curve was calculated according to the trapezoid rule and used for comparison of postprandial values.
Genetic analysis
Selection of candidate genes. The selection of candidate genes was based on their potential contribution to obesity-related phenotypes, their presumed nutrient-sensitive expression and function of the gene products, and the presence of common SNPs with a presumed allele frequency above 0.05. 13 The SNPs were selected through mutation analysis of genes found by positional cloning, mutation analysis of plausible biological candidate genes selected from the literature and found to be associated with functional effects of the gene products, and the available pertinent knowledge about already known obesity-related SNPs.
14 On this basis, 44 SNPs in 28 genes known or presumed to be associated with hypothalamic regulation of appetite, efficiency of EE, regulation of adipocyte differentiation and function, lipid and glucose metabolism or production of several adipocytokines were selected. 13 Table 2 shows the genes and the SNPs that were analyzed for associations with postabsorptive and postprandial EE, respectively. These genes are grouped according to their putative function in relation to the obesity phenotypes. It appears from the positions of the SNPs that some may have functional effects by changing the gene products, some may affect the promoter function, and others may be in linkage disequilibrium with other SNPs with functional effects. They may be considered tag SNPs of potentially functional haplotypes irrespective of their relation to the obesity-related phenotypes or the currently addressed effect on EE. For several of the genes selected (ENPP1, GAD2, CART, SLC6A14, GHRL, PCSK1, ADIPOQ and WAC) a linkage disequilibrium analysis secured an optimal coverage of the genetic variation known at the time of gene selection. The participants not carrying the risk allele were denoted 'noncarriers' corresponding to 'wild types' irrespective of which alleles were most frequent in the present study. For each significant genotype, four genetic models were analyzed. In the first general genetic model, there were no assumptions made about a specific effect of the mutant alleles in the individuals who were heterozygous and homozygous for the gene variant when compared with those who were noncarrier (null hypothesis). Three specific genetic models assume a particular effect of the gene variant compared with the noncarrier: dominant effect Genetics and energy expenditure GH Goossens et al (noncarrier ¼ 0, heterozygous and homozygous ¼ 1), co-dominant effect with equal penetrance (assessed as an additive effect: noncarrier ¼ 0, heterozygous ¼ 1, homozygous ¼ 2), and recessive effect of gene variant (noncarrier ¼ 0, heterozygous ¼ 0, homozygous ¼ 1). For some of the variants, the homozygotes were so rare that identification of recessive transmission or distinction between dominant and co-dominant transmission would not be possible ( Table 2 ).
The regression model addressing the effects of the genotypes on EE (main effects assessed in one model for each genotype) included the genotypes for each variant as covariates. For all the genes in which genotyping was carried out for more than one SNP (Table 2) , haplotype-based analysis was carried out by the program GENECOUNTING (version 1.3), 17 which implements an expectation-maximization algorithm for estimation of the haplotype probabilities in unrelated participants without reference to the phenotype. Subsequently, we estimated the relation between the possible haplotypes on each chromosome and EE by using haplotype pairs for each participant as covariates in regression models with EE as outcome, as has been described earlier. 13 Briefly, this was carried out by multiple imputations. In each of 1000 imputations, a new data set was generated where the haplotype pairs for each participant were drawn at random according to the haplotype probabilities for all the possible haplotypes for each individual as estimated by the GENECOUNTING program. 17 In the basic model to investigate the influence of SNPs on postabsorptive REE, FFM as cubic splines (best fit), age groups, sex and research centre as a random effect were entered (Model 1). The model fit was assessed by testing for the residuals being normally distributed. Thereafter, FM was included linearly in the model (Model 2). Subsequently, based on earlier findings, 3 HOMA IR and plasma free fatty acid (FFAs) were entered linearly (Model 3), followed by linear inclusion of circulating concentrations of plasma IGF-1, serum leptin and plasma cortisol (Model 4). In the analysis of the association between SNPs and postprandial REE, the basic model included, in addition to FFM as cubic splines (best fit), age groups, sex, research centre and REE (Model 1). Thereafter, FM was included linearly (Model 2). Next, HOMA IR and total physical activity were entered linearly (Model 3), as these variables are determinants of postprandial REE. 3 Finally, postprandial plasma insulin concentration was included linearly in the model for the same reason (Model 4). Effect modification by gender was tested.
Results
Postabsorptive REE Table 3 shows the results of the analysis of effects of genotypes on postabsorptive REE while controlling for FFM, age, sex, and research centre (Model 1). The table Genetics and energy expenditure GH Goossens et al presents the difference in EE between the groups of participants who are heterozygous and homozygous for the risk SNPs and those who are homozygous noncarriers of the risk alleles, which thus is the reference group and therefore not depicted. Three SNPs, namely GAD2 À243 A4G (P ¼ 0.03), HSD11B1 G4A (P ¼ 0.05), and LIPC 644 A4G (P ¼ 0.03), were significantly associated with postabsorptive REE in the general genetic model. Analyses of the general effects of the haplotypes on postabsorptive REE demonstrated significant associations for GAD2 (P ¼ 0.03) and LIPC (Po0.001). Variants in FTO (P ¼ 0.87), UCP2 (P ¼ 0.60) and UCP3 (P ¼ 0.38) were not associated with postabsorptive REE.
There were statistically significant associations between SNPs and postabsorptive REE from specific genetic models adjusted for FFM, age, sex and research centre (Model 1). In single tests, significant associations with postabsorptive REE were found for CART À3608 T4C (co-dominant), CART The test for association between the haplotypes of the genes where more than one SNP were genotyped is carried out as a global test for the possible haplotypes (see Materials and methods section for details).
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GH Goossens et al À175 A4G (co-dominant), GAD2 þ 83897 T4A (co-dominant), GAD2 À243 A4G (dominant and co-dominant), PCSK1 T690S C4G (recessive), PPARG3 À681 C4G (dominant), HSD11B1 G4A (dominant and co-dominant), and LIPC 644 A4G (dominant) ( Table 4) . When, in addition to FFM, age, sex and research centre (Model 1), postabsorptive REE was adjusted for FM (Model 2), GAD2 À243 A4G (dominant and co-dominant, both P ¼ 0.02), HSD11B1 G4A (dominant and co-dominant, both P ¼ 0.04) and LIPC 644 A4G (dominant, P ¼ 0.01) remained significantly associated with postabsorptive REE (Table 4) . After further adjustment of postabsorptive REE for HOMA IR and plasma FFA concentration (Model 3), only GAD2 À243 A4G (dominant and co-dominant, both P ¼ 0.01) and LIPC 644 A4G (dominant, P ¼ 0.01) remained significantly associated with postabsorptive REE. Finally, further inclusion of circulating concentrations of plasma insulin-like growth factor-1 (IGF-1), serum leptin and plasma cortisol in the model (Model 4) did not significantly affect the associations between these SNPs and postabsorptive REE (Table 4) .
Postprandial REE
Results of the analysis of effects of genotypes on postprandial REE, while controlling for FFM, age, sex and research centre (Model 1), are depicted in Table 5 . The table presents the difference in postprandial REE between the groups of participants who are heterozygous and homozygous for the risk SNPs versus homozygous noncarriers of the risk alleles (reference group).
CART À1336 delA (P ¼ 0.05) and PPARG2 1431 C4T (P ¼ 0.02) were significantly associated with postprandial REE in the general genetic model. None of the haplotypes had statistically significant influence on postprandial REE. Variants in FTO (P ¼ 0.89), UCP2 (P ¼ 0.78) and UCP3 (P ¼ 0.40) were not associated with postprandial REE.
There were significant associations between SNPs and postprandial REE from specific genetic models adjusted for FFM, age, sex, research centre and REE (Model 1). In single tests, significant associations with postprandial REE were found for CART À1336 delA (dominant and co-dominant), PPARG2 1431 C4T (dominant and co-dominant) and IGF2 Apal A4G (co-dominant) (Table 6) .
When, in addition to FFM, age, sex, research centre and postabsorptive REE (Model 1), postprandial REE was adjusted for FM (Model 2) and, thereafter, HOMA IR and total physical activity (Model 3), the above-mentioned associations remained statistically significant (Table 6 ). Further inclusion of postprandial plasma insulin concentration in the model (Model 4) did not significantly affect the associations between CART À1336 delA and PPARG2 1431 C4T and postprandial REE, but the association between IGF2 Apal A4G and postprandial REE became statistically nonsignificant (Table 6) .
Discussion
This study showed that several obesity-related gene variants are significantly associated with postabsorptive REE and postprandial REE. Thus, genetic differences between obese individuals may contribute to the diversity of the obesity phenotype. Importantly, these findings should be interpreted with some caution, as the results were not adjusted for multiple testing. Therefore, replication of our findings in subsequent studies is needed.
The genes in which significant effects upon EE were shown belonged to several different categories of presumed function in the obesity-related phenotypes (Table 2) : CART, GAD2, PCSK1 may be involved in hypothalamic regulation of appetite, PPARG2 and PPARG3 in regulation of adipocyte Genetics and energy expenditure GH Goossens et al differentiation and function and HSD11B1, LIPC and IGF2 in lipid and glucose metabolism.
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Postabsorptive REE On the basis of the present analyses, SNPs in genes that may be involved in hypothalamic regulation of appetite, regulation of adipocyte differentiation and function, and in the regulation of lipid and glucose metabolism were associated with postabsorptive REE. GAD2 þ 83897 T4A, GAD2 À243 A4G, CART À3608 C4T, CART À175 A4G and PPARG3 À681 C4G were associated with an increase in postabsorptive REE, whereas PCSK1 T690S C4G, HSD11B1 G4A and LIPC 644 A4G were associated with reduced postabsorptive REE in obese individuals. When, in addition to FFM, age, sex and research centre, postabsorptive REE was adjusted for FM, HSD11B1 G4A, GAD2 À243 A4G and LIPC 644 A4G remained significantly b The test for association between the haplotypes of the genes where more than one SNP were genotyped is carried out as a global test for the possible haplotypes (see Materials and methods section for details).
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GH Goossens et al associated with postabsorptive REE. These data suggest that HSD11B1 G4A, GAD2 À243 A4G and LIPC 644 A4G may influence postabsorptive REE independent of changes in body composition, indicating an effect on adaptive thermogenesis 7 Conflicting data have been reported with respect to associations between SNPs in GAD2 and CART and obesity. [18] [19] [20] [21] These opposing findings may partly be due to effects of GAD2 À243 A4G on both energy intake (higher hunger and disinhibition scores) 19 and, based on the present data, increased postabsorptive REE. CART is an anorectic peptide that is expressed in hypothalamic areas and is involved in the control of feeding behaviour. 22 CART À3608
T4C has been reported to associate positively with obesity. 20 The present finding that the À175 G allele in the CART gene may increase postabsorptive REE in obese individuals is in accordance with findings showing that CART expression is reduced in situations where EE is decreased. 23, 24 In contrast to findings on postabsorptive REE, CART À1336 delA was associated with reduced postprandial REE in this study. Furthermore, we show that GAD2 þ 83897 T4A, CART À3608 C4T, CART À175 A4G, PPARG3 À681 C4G and PCSK1 T690S C4G may exert effects on postabsorptive REE by modulation of FM. After further adjustment of postabsorptive REE for HOMA IR and plasma FFA concentration, only GAD2 À243 A4G and LIPC 644 A4G remained significantly associated with postabsorptive REE. These data indicate that HSD11B1 G4A may decrease postabsorptive REE through an effect upon insulin sensitivity and/or plasma FFA concentration, but this suggestion is based on associations and requires further confirmation. The decrease in postabsorptive REE seems consistent with earlier findings showing weak associations between HSD11B1 genotype, 11b-HSD1 activity and waist-hip ratio. 25 The underlying mechanism for this finding is hypothesized to be altered autocrine conversion of inactive cortisone to active cortisol by 11b-HSD1 in adipose tissue, 25 which may subsequently affect adipose tissue lipolysis.
It is important to note that the different regression models to assess the effects of the covariates on the association between the SNPs and EE were used to obtain some insight into possible underlying mechanisms. The different covariates (for example, FM, HOMA IR and plasma FFA concentration) only had a very modest effect on the association between the SNPs and postabsorptive REE (Table 4) . Therefore, these findings need to be interpreted with caution, and the possible association between these SNPs and the covariates should be further elucidated in future studies.
Postprandial REE
Postprandial REE was associated with CART À1336 delA, PPARG2 1431 C4T and IGF2 Apal A4G. PPARG2 1431 C4T was associated with increased postprandial REE, whereas CART À1336 delA and IGF2 Apal had opposite effects.
After adjustment for FM, HOMA IR and total physical activity, the association between CART À1336 delA, PPARG2 1431 C4T and IGF2 Apal A4G and postprandial REE remained significant. These data indicate that CART À1336 delA, PPARG2 1431 C4T and IGF2 Apal A4G may be involved in adaptations in thermogenesis independent of body composition. 7 The present finding that PPARG2 1431
C4T increased postprandial REE, together with an earlier report showing that individuals with the Pro12Ala polymorphism of PPARG2 had an increased postprandial REE and higher satiety, 26 suggest that PPARG2 polymorphisms may play a role in postprandial REE. The association between IGF2 Apal A4G and postprandial REE became statistically nonsignificant when further adjusted for postprandial plasma insulin concentration. Thus, it appears that IGF2 Apal A4G may decrease postprandial REE through effects on postprandial insulin concentrations, possibly through effects on sympathetically mediated thermogenesis. 27 IGF2 Apal A4G has previously been shown to be positively associated with body mass index 28 and body weight. 29 The present data suggest that this relationship may, at least partly, be explained by decreased postprandial REE. Interestingly, the FTO variant was not significantly associated with postabsorptive and postprandial REE in this study. It has been reported recently that the SNP in FTO we have examined in the present study predisposed to type 2 diabetes through an effect on body mass index. 6 Very recently, it has been found that FTO catalyzes Fe(II)-and Genetics and energy expenditure GH Goossens et al 2-oxoglutarate-dependent DNA demethylation. 30 FTO was found highly expressed in the hypothalamus, a tissue involved in the control of energy balance, and FTO mRNA expression was nutritionally regulated. 30 Although it remains to be established whether altered FTO demethylase activity underlies the increased adipose tissue mass associated with the FTO variant, and whether this alteration is related with increased food intake and/or decreased EE, our data suggest that this may not be mediated directly through an effect on EE. This is in line with a recent study showing that homozygous carriers of the A-allele of this FTO variant do not have lower postabsorptive REE. 31 Likewise, TCF7L2
C4T was not associated with postabsorptive and postprandial EE in this study. It has recently been reported that common variants in the TCF7L2 gene increase the risk of type 2 diabetes, 32 which may be due to effects on insulin secretion, hepatic glucose production and incretin effects 33 rather than modulation of EE. In addition, SNPs in the candidate genes that have been linked with efficiency of EE, namely UCP2 and UCP3, showed no effects on EE in this study. In line with our findings, other investigators have shown that postabsorptive REE did not differ according to UCP2 genotype. 34, 35 In contrast, postabsorptive REE has earlier been shown to be increased in carriers of the UCP3 À55C4T polymorphism, but conflicting data with respect to SNPs in the UCP3 gene and obesity risk have been reported. [36] [37] [38] This may not be surprising as the prevailing opinion is that the primary function of UCP3 is not the regulation of energy metabolism. 39 Finally, we did not observe a significant association between SNPs in inflammation-related genes, such as IL-6 À174 G4C. IL-6 (interleukin-6) has been shown to enhance EE in animal models. 40 The impact of this cytokine on energy balance in humans remains to be elucidated, although it has recently been shown that IL-6 À174 G4C protects against weight regain after weight loss, and may therefore play a role in weight regulation. 41 In conclusion, the results of this study suggest that several gene polymorphisms associated with obesity-related phenotypes but not FTO and UCP variants may be responsible for some of the inter-individual variability in postabsorptive REE and fat-induced thermogenesis unaccounted for by FFM, FM, age and sex. These genetic differences between obese individuals may therefore contribute to the heterogeneity of the obesity phenotype. The association between FTO and obesity that has previously been shown may not be mediated directly through modulation of EE in obese individuals.
